Vertex Pharmaceuticals Financials

Values in thousands	2026-09-30	2026-06-30	2026-03-31	2025-12-31
Revenue	$3,440,800	$3,333,900	$2,986,900	$3,227,100
Gross Profit	2,914,700	2,844,700	2,594,100	2,761,100
EBITDA	712,900	1,448,700	1,308,800	1,390,000
EBIT		1,392,200	1,252,900	1,334,300
Net Income	653,600	1,099,800	1,031,400	1,191,100
Net Change In Cash	3,440,800	3,333,900	2,986,900	3,227,100
Free Cash Flow		1,013,200	1,294,700	348,600
Cash		6,143,500	5,492,900	5,087,800
Basic Shares	255,200	255,700	256,300	256,100

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$12,074,600	$11,020,100	$9,869,200	$8,930,700
Gross Profit	10,267,500	9,489,600	8,607,000	7,850,400
EBITDA	4,866,300	486,300	4,605,200	4,435,500
EBIT	4,656,500	279,100	4,423,900	4,287,200
Net Income	3,953,200	-535,600	3,619,600	3,322,000
Net Change In Cash	12,074,600	11,020,100	9,869,200	8,930,700
Cost of Revenue				3,741,100
Free Cash Flow	3,193,800	-790,300	3,278,900	3,925,200
Cash	5,087,800	4,569,600	10,369,100	10,504,000
Basic Shares	258,000	257,900	260,500	259,100